Literature DB >> 26472914

Structural basis of histone H3K27 trimethylation by an active polycomb repressive complex 2.

Lianying Jiao1, Xin Liu2.   

Abstract

Polycomb repressive complex 2 (PRC2) catalyzes histone H3K27 trimethylation (H3K27me3), a hallmark of gene silencing. Here we report the crystal structures of an active PRC2 complex of 170 kilodaltons from the yeast Chaetomium thermophilum in both basal and stimulated states, which contain Ezh2, Eed, and the VEFS domain of Suz12 and are bound to a cancer-associated inhibiting H3K27M peptide and a S-adenosyl-l-homocysteine cofactor. The stimulated complex also contains an additional stimulating H3K27me3 peptide. Eed is engulfed by a belt-like structure of Ezh2, and Suz12(VEFS) contacts both of these two subunits to confer an unusual split active SET domain for catalysis. Comparison of PRC2 in the basal and stimulated states reveals a mobile Ezh2 motif that responds to stimulation to allosterically regulate the active site.
Copyright © 2015, American Association for the Advancement of Science.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26472914      PMCID: PMC5220110          DOI: 10.1126/science.aac4383

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  44 in total

1.  Substrate preferences of the EZH2 histone methyltransferase complex.

Authors:  Cyrus Martin; Ru Cao; Yi Zhang
Journal:  J Biol Chem       Date:  2006-01-23       Impact factor: 5.157

2.  Structural basis of EZH2 recognition by EED.

Authors:  Zhifu Han; Xinmiao Xing; Min Hu; Yin Zhang; Peiyuan Liu; Jijie Chai
Journal:  Structure       Date:  2007-10       Impact factor: 5.006

Review 3.  Transcriptional regulation by Polycomb group proteins.

Authors:  Luciano Di Croce; Kristian Helin
Journal:  Nat Struct Mol Biol       Date:  2013-10       Impact factor: 15.369

4.  Polycomb-dependent H3K27me1 and H3K27me2 regulate active transcription and enhancer fidelity.

Authors:  Karin J Ferrari; Andrea Scelfo; Sriganesh Jammula; Alessandro Cuomo; Iros Barozzi; Alexandra Stützer; Wolfgang Fischle; Tiziana Bonaldi; Diego Pasini
Journal:  Mol Cell       Date:  2013-11-27       Impact factor: 17.970

Review 5.  A new world of Polycombs: unexpected partnerships and emerging functions.

Authors:  Yuri B Schwartz; Vincenzo Pirrotta
Journal:  Nat Rev Genet       Date:  2013-11-12       Impact factor: 53.242

6.  Dense chromatin activates Polycomb repressive complex 2 to regulate H3 lysine 27 methylation.

Authors:  Wen Yuan; Tong Wu; Hang Fu; Chao Dai; Hui Wu; Nan Liu; Xiang Li; Mo Xu; Zhuqiang Zhang; Tianhui Niu; Zhifu Han; Jijie Chai; Xianghong Jasmine Zhou; Shaorong Gao; Bing Zhu
Journal:  Science       Date:  2012-08-24       Impact factor: 47.728

7.  Clinical effect of point mutations in myelodysplastic syndromes.

Authors:  Rafael Bejar; Kristen Stevenson; Omar Abdel-Wahab; Naomi Galili; Björn Nilsson; Guillermo Garcia-Manero; Hagop Kantarjian; Azra Raza; Ross L Levine; Donna Neuberg; Benjamin L Ebert
Journal:  N Engl J Med       Date:  2011-06-30       Impact factor: 91.245

8.  Different EZH2-containing complexes target methylation of histone H1 or nucleosomal histone H3.

Authors:  Andrei Kuzmichev; Thomas Jenuwein; Paul Tempst; Danny Reinberg
Journal:  Mol Cell       Date:  2004-04-23       Impact factor: 17.970

Review 9.  The Polycomb complex PRC2 and its mark in life.

Authors:  Raphaël Margueron; Danny Reinberg
Journal:  Nature       Date:  2011-01-20       Impact factor: 49.962

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  160 in total

Review 1.  Polycomb and Trithorax Group Genes in Drosophila.

Authors:  Judith A Kassis; James A Kennison; John W Tamkun
Journal:  Genetics       Date:  2017-08       Impact factor: 4.562

Review 2.  Touch, act and go: landing and operating on nucleosomes.

Authors:  Valentina Speranzini; Simona Pilotto; Titia K Sixma; Andrea Mattevi
Journal:  EMBO J       Date:  2016-01-19       Impact factor: 11.598

3.  Antigen clasping by two antigen-binding sites of an exceptionally specific antibody for histone methylation.

Authors:  Takamitsu Hattori; Darson Lai; Irina S Dementieva; Sherwin P Montaño; Kohei Kurosawa; Yupeng Zheng; Louesa R Akin; Kalina M Świst-Rosowska; Adrian T Grzybowski; Akiko Koide; Krzysztof Krajewski; Brian D Strahl; Neil L Kelleher; Alexander J Ruthenburg; Shohei Koide
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-09       Impact factor: 11.205

4.  Architecture of PRC2 Holo Complexes.

Authors:  Kendra R Vann; Tatiana G Kutateladze
Journal:  Trends Biochem Sci       Date:  2018-05-03       Impact factor: 13.807

5.  C10ORF12 modulates PRC2 histone methyltransferase activity and H3K27me3 levels.

Authors:  Yi Shi; Hong-Lei Ma; You-Wen Zhuang; Xiao-Xi Wang; Yi Jiang; H Eric Xu
Journal:  Acta Pharmacol Sin       Date:  2019-06-11       Impact factor: 6.150

Review 6.  Polycomb repressive 2 complex-Molecular mechanisms of function.

Authors:  Valentina L Kouznetsova; Alex Tchekanov; Xiaoming Li; Xiaowen Yan; Igor F Tsigelny
Journal:  Protein Sci       Date:  2019-06-10       Impact factor: 6.725

Review 7.  Inhibitors of Protein Methyltransferases and Demethylases.

Authors:  H Ümit Kaniskan; Michael L Martini; Jian Jin
Journal:  Chem Rev       Date:  2017-03-24       Impact factor: 60.622

Review 8.  Recent progress in developing selective inhibitors of protein methyltransferases.

Authors:  H Ümit Kaniskan; Jian Jin
Journal:  Curr Opin Chem Biol       Date:  2017-06-26       Impact factor: 8.822

9.  Polycomb repressive complex 2 in an autoinhibited state.

Authors:  Matthew Bratkowski; Xin Yang; Xin Liu
Journal:  J Biol Chem       Date:  2017-06-12       Impact factor: 5.157

10.  Response to Comment on "Structural basis of histone H3K27 trimethylation by an active polycomb repressive complex 2".

Authors:  Lianying Jiao; Xin Liu
Journal:  Science       Date:  2016-12-23       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.